C07C 323/53
The carbon skeleton being saturated and containing rings
Official title: the carbon skeleton being saturated and containing rings
C07C323/53 (The carbon skeleton being saturated and containing rings) appears on 15 US grants and 16 published applications in this corpus.
Search patents in C07C- Granted patents
- 15
- Published applications
- 16
- Assignees
- 23
- Inventors
- 95
- Latest grant
- 14 Jul 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 0 | 1 |
| 2015 | 3 | 1 |
| 2016 | 0 | 2 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 2 | 2 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Sulfide alkyl compounds for HBV treatment14 Jul 2020US 10,710,959 B2Novira Therapeutics, Inc.
- Biaryl derivatives as GPR120 agonists5 Mar 2019US 10,221,138 B2LG Chem.Ltd.
- Sulfide alkyl compounds for HBV treatment5 Feb 2019US 10,196,351 B2Novira Therapeutics, Inc.
- Sulfide alkyl compounds for HBV treatment21 Mar 2017US 9,597,332 B2Novira Therapeutics, Inc.
- Phenylthioacetate compounds, compositions and methods of use15 Dec 2015US 9,212,135 B2Ardea Biosciences, Inc.
- Platinum complexes, related compositions, and uses thereof in cyanide counter-measures30 Jul 2026US 2026/0216120 A1Beth Israel Deaconess Medical Center, Inc.
- Organic salt, resist composition including the same, and pattern formation method using the resist composition25 Jun 2026US 2026/0177911 A1Samsung Electronics Co., Ltd.
- Compounds for the Treatment of Neuromuscular Disorders8 Jan 2026US 2026/0007625 A1Nmd Pharma A/S
- Fatty acid derivative labeled with positron-emitting radionuclide2 Mar 2023US 2023/0065079 A1Astellas Pharma Inc.
- Sulfide alkyl compounds for hbv treatment4 Jul 2019US 2019/0202780 A1Novira Therapeutics, Inc.
Most cited
By later US patents
- Process for the preparation of leukotriene anatgonists29US 5,614,632 AMerck & Co., Inc. · 1997
- Bis(aryloxy)alkanes as inhibitors of phospholipase A.sub.2 enzymes19US 5,453,443 AMerck Frosst Canada, Inc. · 1995
- Process for the preparation of leukotriene antagonists12US 6,320,052 B1Merck & Co., Inc. · 2001
- Process for producing 3-formylcyclopentanone derivatives10US 4,073,799 A(Zaidanhojin) Sagami Chemical Research Center · 1978
- Bicycloheptane substituted ethers9US 4,647,585 AE. R. Squibb & Sons, Inc. · 1987